- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Faes Farma SA (FFEA)
| Open: | 2.043 | Day's Range: | 2.043 - 2.043 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 2.005 | 52wk Range: | 1.096 - 2.487 | 1-Yr Rtn: | +81.69% |
Key Statistics for FFEA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 20.4300 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (EUR) (ttm) | - |
| Est. EPS (EUR) (12/2013) | 0.1000 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 168 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 1.88% |
| Cash Dividend (EUR) | 0.0228 |
| Last Dividend | 12/21/2012 |
| 5 Year Dividend Growth | -7.06% |
| Next Earnings Announcement | 07/17/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for FFEA
Company Profile & Key Executives for FFEA
Faes Farma, S.A. develops, manufactures and markets pharmaceutical products throughout Spain and, through its subsidiary, Laboratorios Vitoria S.A., in Portugal. The Company's principal prescription products combat cardiovascular, respiratory, central nervous system, musculoskeletal and osteoporosis related ailments.
| Eduardo Fernandez De Valderrama MurilloChairman | Mariano Ucar AnguloVice Chairman |
| Francisco Quintanilla GuerraChief Executive Officer | Luis ProencaGen Dir:Portugal |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
FFEA News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page